Correlation of SIN3A Genomic Variants with β-Hemoglobinopathies Disease Severity and Hydroxyurea Treatment Efficacy

References

• Cao A , GalanelloR . Beta-thalassemia . Genet. Med.12 ( 2 ), 61 – 76 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Nienhuis AW , NathanDG . Pathophysiology and clinical manifestations of the β-thalassemias . Cold Spring Harb. Perspect. Med.2 ( 12 ), a011726 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Wilber A , NienhuisAW , PersonsDA . Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities . Blood117 ( 15 ), 3945 – 3953 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Thein SL , MenzelS , LathropM , GarnerC . Control of fetal hemoglobin: new insights emerging from genomics and clinical implications . Hum. Mol. Genet.18 ( R2 ), R216 – R223 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Thein SL . Genetic modifiers of the beta-haemoglobinopathies . Br. J. Haematol.141 ( 3 ), 357 – 366 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Weatherall DJ . Phenotype–genotype relationships in monogenic disease: lessons from the thalassaemias . Nat. Rev. Genet.2 ( 4 ), 245 – 255 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Özdemir V , DoveES , GürsoyUKet al. Personalized medicine beyond genomics: alternative futures in big data – proteomics, environtome and the social proteome . J. Neural Transm. (Vienna) ( 2015 ) ( Epub ahead of print ).
   PubMed Web of Science ®Google Scholar
• Testa U . Fetal hemoglobin inducers for treatment of hemoglobinopathies . Ann. Hematol.88 ( 6 ), 505 – 528 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Perrine SP , PaceBS , FallerDV . Targeted fetal hemoglobin induction for treatment of beta hemoglobinopathies . Hematol. Oncol. Clin. North Am.28 ( 2 ), 233 – 248 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Cokic VP , SmithRD , Beleslin-CokicBBet al. Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase . J. Clin. Invest.111 ( 2 ), 231 – 239 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Ma Q , WyszynskiDF , FarrellJJet al. Fetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea . Pharmacogenomics J.7 ( 6 ), 386 – 394 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Italia KY , JijinaFF , MerchantRet al. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India . Clin. Chim. Acta407 , 10 – 15 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Chalikiopoulou C , TavianatouAG , SgourouAet al. Genomic variants in the ASS1 gene, involved in the nitric oxide biosynthesis and signaling pathway, predict hydroxyurea treatment efficacy in compound sickle cell disease/β-thalassemia patients . Pharmacogenomics17 ( 4 ), 393 – 403 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Tafrali C , PaiziA , BorgJet al. Genomic variation in the MAP3K5 gene is associated with β-thalassemia disease severity and hydroxyurea treatment efficacy . Pharmacogenomics14 ( 5 ), 469 – 483 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Borg J , PhylactidesM , BartsakouliaMet al. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients . Pharmacogenomics13 ( 13 ), 1487 – 1500 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Siatecka M , BiekerJJ . The multifunctional role of EKLF/KLF1 during erythropoiesis . Blood118 ( 8 ), 2044 – 2054 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhang JS , MoncrieffeMC , KaczynskiJet al. A conserved α-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A . Mol. Cell. Biol.21 ( 15 ), 5041 – 5049 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Giannopoulou E , BartsakouliaM , TafraliCet al. A single nucleotide polymorphism in the HBBP1 gene in the human β-globin locus is associated with a mild β-thalassemia disease phenotype . Hemoglobin36 ( 5 ), 433 – 445 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Papachatzopoulou A , KaimakisP , PourfarzadFet al. Increased γ-globin gene expression in β-thalassemia intermedia patients correlates with a mutation in 3′HS1 . Am. J. Hematol.82 ( 11 ), 1005 – 1009 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Papachatzopoulou A , KourakliA , MakropoulouPet al. Genotypic heterogeneity and correlation to intergenic haplotype within high HbF β-thalassemia intermedia . Eur. J. Haematol.76 ( 4 ), 322 – 330 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Musallam KM , TaherAT , RachmilewitzEA . β-thalassemia intermedia: a clinical perspective . Cold Spring Harb. Perspect. Med.2 ( 7 ), a013482 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Patrinos GP , GrosveldFG . Pharmacogenomics and therapeutics of hemoglobinopathies . Hemoglobin32 ( 1–2 ), 229 – 236 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• AltAnalyze . www.altanalyze.org .
   Google Scholar
• Borg J , PapadopoulosP , GeorgitsiMet al. Haploinsufficiency for the erythroid transcription factor KLF1 causes hereditary persistence of fetal hemoglobin . Nat. Genet.42 ( 9 ), 801 – 805 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• National Center for Biotechnology Information . http://hapmap.ncbi.nlm.nih.gov/index.html.en .
   Google Scholar
• Xu Z , TaylorJA . SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies . Nucleic Acids Res.37 , W600 – W605 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• SNPinfo . http://snpinfo.niehs.nih.gov/snpinfo/snptag.htm .
   Google Scholar
• Barrett JC , FryB , MallerJ , DalyMJ . Haploview: analysis and visualization of LD and haplotype maps . Bioinformatics21 ( 2 ), 263 – 265 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• STRING . http://string-db.org/ .
   Google Scholar
• Szklarczyk D , FranceschiniA , WyderSet al. STRING v10: protein–protein interaction networks, integrated over the tree of life . Nucleic Acids Res.43 , D447 – D452 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Ikuta T , KuroyanagiY , OdoN , LiuS . A common signaling pathway is activated in erythroid cells expressing high levels of fetal hemoglobin: a potential role for cAMP-elevating agents in β-globin disorders . J. Blood Med.4 , 149 – 159 ( 2013 ).
   PubMedGoogle Scholar
• Ramakrishnan V , PaceBS . Regulation of γ-globin gene expression involves signaling through the p38 MAPK/CREB1 pathway . Blood Cells Mol. Dis.47 ( 1 ), 12 – 22 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Zhu J , ChinK , AerbajinaiWet al. Hydroxyurea-inducible SAR1 gene acts through the Giα/JNK/Jun pathway to regulate γ-globin expression . Blood124 ( 7 ), 1146 – 1156 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Banan M . Hydroxyurea treatment in β-thalassemia patients: to respond or not to respond?Ann. Hematol.92 ( 3 ), 289 – 299 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Green NS , EnderKL , PashankarFet al. Candidate sequence variants and fetal hemoglobin in children with sickle cell disease treated with hydroxyurea . PLoS ONE8 ( 2 ), e55709 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Gravia A , ChondrouV , SgourouAet al. Individualizing fetal hemoglobin augmenting therapy for β-type hemoglobinopathies patients . Pharmacogenomics15 ( 10 ), 1355 – 1364 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Squassina A , ManchiaM , ManolopoulosVGet al. Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice . Pharmacogenomics11 ( 8 ), 1149 – 1167 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Ginder GD . Epigenetic regulation of fetal globin gene expression in adult erythroid cells . Transl. Res.165 ( 1 ), 115 – 125 ( 2015 ).
   PubMed Web of Science ®Google Scholar
• Kim MS , PintoSM , GetnetDet al. A draft map of the human proteome . Nature509 ( 7502 ), 575 – 581 ( 2014 ).
   PubMed Web of Science ®Google Scholar